Cholesterol: Point-of-care testing

Annals of Pharmacotherapy

Volumn 38, Issue 7-8, 2004, Pages 1252-1257

  Taylor, James R ^a   Lopez, Larry M ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Hyperlipidemia; Point of care tests

Indexed keywords

CHOLESTEROL;

CAUSE OF DEATH; CORONARY ARTERY DISEASE; DEVICE; HUMAN; HYPERLIPIDEMIA; MONITOR; PATIENT EDUCATION; PHARMACIST; PHARMACY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SYSTEMATIC REVIEW; UNITED STATES;

CHOLESTEROL; COMMUNITY PHARMACY SERVICES; COSTS AND COST ANALYSIS; DIAGNOSTIC EQUIPMENT; HUMANS; HYPERLIPIDEMIAS; PATIENT EDUCATION; POINT-OF-CARE SYSTEMS;

EID: 3042601409     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D269     Document Type: Review

References (16)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
2. Anda RF, Waller MN, Wooten KG, Mast EE, Escobedo LG, Sanderson LM. Behavioral risk factor surveillance, 1988. In: MMWR CDC Surveill Summ 1990;39:1-21. Erratum 1990;39:437.
3. Bachorik PS. Measurement of total cholesterol, HDL-cholesterol, and LDL-cholesterol. Clin Lab Med 1989;9:61-71.
4. Allain CC, Poon LS, Cha CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
5. First Check Home cholesterol test. www.wwmed.com (accessed 2003 May 9).
6. Santee J. Accuracy and precision of the Cholestech LDX system in monitoring blood lipid levels. Am J Health Syst Pharm 2002;59:1774-9.
7. National Cholesterol Education Program. Current status of blood cholesterol measurement in clinical laboratories in the United States: a report from the standardization panel of the National Cholesterol Education Program. Clin Chem 1988;34:193-201.
8. Bachorik PS, Ross JW, for the National Cholesterol Education Program Working Group on Lipoprotein Measurement. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. Clin Chem 1995;41:1414-20.
9. Warnick JR, Wood PD, for the National Cholesterol Education Program Working Group on Lipoprotein Measurement. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. Clin Chem 1995;41:1427-33.
10. Stein EA, Myers GL, for the National Cholesterol Education Program Working Group on Lipoprotein Measurement. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. Clin Chem 1995;41:1421-6.
11. Volles DF, McKenney JM, Miller WG, Ruffen D, Zhang D. Analytic and clinical performance of two compact cholesterol-testing devices. Pharmacotherapy 1998;18:184-92.
12. Bard RL, Kaminsky LA, Whaley MH, Zajakowski S. Evaluation of lipid profile measurements obtained from the Cholestech LDX analyzer. J Cardiopulm Rehabil 1997;17:413-8.
13. Rogers EJ, Misner L, Ockene IS, Nicolosi RJ. Evaluation of seven Cholestech LDX analyzers for total cholesterol determinations. Clin Chem 1993;39:860-4.
14. Cobbaert C, Boerma GJ, Lindemans J. Evaluation of the Cholestech LDX desktop analyser for cholesterol, HDL-cholesterol, and triacyglycerols in heparinized venous blood. Eur J Clin Chem Clin Biochem 1994;32:391-4.
15. Gregory LC, Duh SC, Christenson RH. Eight compact analysis systems evaluated for measuring total cholesterol. Clin Chem 1994;40:579-85.
16. Stein JH, Carlsson CM, Papcke-Benson K, Einerson JA, McBride PE, Wiebe DA. Inaccuracy of lipid measurements with the portable Cholestech LDX analyzer in patients with hypercholesterolemia. Clin Chem 2002;48:284-90.